{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,20]],"date-time":"2026-07-20T14:17:37Z","timestamp":1784557057810,"version":"3.55.0"},"reference-count":18,"publisher":"Bioscientifica","license":[{"start":{"date-parts":[[2018,11,22]],"date-time":"2018-11-22T00:00:00Z","timestamp":1542844800000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/3.0\/deed.en_GB"}],"content-domain":{"domain":["edm.bioscientifica.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2018,11,22]]},"abstract":"<jats:title>Summary<\/jats:title>\n                  <jats:p>Addison\u2019s disease (AD) is the most common endocrine manifestation of antiphospholipid syndrome (APS), but it remains a very rare complication of the syndrome. It is caused by adrenal venous thrombosis and consequent hemorrhagic infarction or by spontaneous (without thrombosis) adrenal hemorrhage, usually occurring after surgery or anticoagulant therapy. We present a clinical case of a 36-year-old female patient with a previous diagnosis of APS. She presented with multiple thrombotic events, including spontaneous abortions. During evaluation by the third episode of abortion, a CT imaging revealed an adrenal hematoma, but the patient was discharged without further investigation. A few weeks later, she presented in the emergency department with manifestations suggestive of adrenal insufficiency. Based on that assumption, she started therapy with glucocorticoids, with significant clinical improvement. After stabilization, additional investigation confirmed AD and excluded other etiologies; she also started mineralocorticoid replacement. This case illustrates a rare complication of APS that, if misdiagnosed, may be life threatening. A high index of suspicion is necessary for its diagnosis, and prompt treatment is crucial to reduce the morbidity and mortality potentially associated.<\/jats:p>\n                  <jats:sec>\n                    <jats:title>Learning points:<\/jats:title>\n                    <jats:list list-type=\"bullet\">\n                      <jats:list-item>\n                        <jats:p>AD is a rare but life-threatening complication of APS.<\/jats:p>\n                      <\/jats:list-item>\n                      <jats:list-item>\n                        <jats:p>It is important to look for AD in patients with APS and a suggestive clinical scenario.<\/jats:p>\n                      <\/jats:list-item>\n                      <jats:list-item>\n                        <jats:p>APS must be excluded in patients with primary adrenal insufficiency and adrenal imaging revealing thrombosis\/hemorrhage.<\/jats:p>\n                      <\/jats:list-item>\n                      <jats:list-item>\n                        <jats:p>Glucocorticoid therapy should be promptly initiated when AD is suspected.<\/jats:p>\n                      <\/jats:list-item>\n                      <jats:list-item>\n                        <jats:p>Mineralocorticoid replacement must be started when there is confirmed aldosterone deficiency.<\/jats:p>\n                      <\/jats:list-item>\n                      <jats:list-item>\n                        <jats:p>Hypertension is a common feature of APS; in patients with APS and AD, replacement therapy with glucocorticoids and mineralocorticoids may jeopardize hypertension management.<\/jats:p>\n                      <\/jats:list-item>\n                    <\/jats:list>\n                  <\/jats:sec>","DOI":"10.1530\/edm-18-0118","type":"journal-article","created":{"date-parts":[[2018,11,27]],"date-time":"2018-11-27T07:48:27Z","timestamp":1543304907000},"update-policy":"https:\/\/doi.org\/10.1530\/crossmarkpolicy-2","source":"Crossref","is-referenced-by-count":5,"title":["Addison\u2019s disease in antiphospholipid syndrome: a rare complication"],"prefix":"10.1530","volume":"2018","author":[{"given":"Diana","family":"Oliveira","sequence":"first","affiliation":[{"name":"Endocrinology, Diabetes and Metabolism Department, Centro Hospitalar e Universitario de Coimbra EPE, Coimbra, Portugal"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mara","family":"Ventura","sequence":"additional","affiliation":[{"name":"Endocrinology, Diabetes and Metabolism Department, Centro Hospitalar e Universitario de Coimbra EPE, Coimbra, Portugal"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Miguel","family":"Melo","sequence":"additional","affiliation":[{"name":"Endocrinology, Diabetes and Metabolism Department, Centro Hospitalar e Universitario de Coimbra EPE, Coimbra, Portugal"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sandra","family":"Paiva","sequence":"additional","affiliation":[{"name":"Endocrinology, Diabetes and Metabolism Department, Centro Hospitalar e Universitario de Coimbra EPE, Coimbra, Portugal"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francisco","family":"Carrilho","sequence":"additional","affiliation":[{"name":"Endocrinology, Diabetes and Metabolism Department, Centro Hospitalar e Universitario de Coimbra EPE, Coimbra, Portugal"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"416","reference":[{"key":"ref11","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1177\/0961203309106832","article-title":"The Euro-Phospholipid project: epidemiology of the antiphospholipid syndrome in Europe","volume":"18","year":"2009","journal-title":"Lupus"},{"key":"ref101","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1177\/0961203309106832","article-title":"The Euro-Phospholipid project: epidemiology of the antiphospholipid syndrome in Europe","volume":"18","year":"2009","journal-title":"Lupus"},{"key":"ref161","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1210\/edrv.23.3.0466","article-title":"Autoimmune adrenal insufficiency and autoimmune polyendocrine syndromes: autoantibodies, autoantigens, and their applicability in diagnosis and disease prediction","volume":"23","year":"2002","journal-title":"Endocrine Reviews"},{"key":"ref151","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1210\/jc.2015-1710","article-title":"Diagnosis and treatment of primary adrenal insufficiency: An endocrine society clinical practice guideline","volume":"101","year":"2016","journal-title":"Journal of Clinical Endocrinology and Metabolism"},{"key":"ref171","doi-asserted-by":"crossref","first-page":"999","DOI":"10.1136\/ard.62.10.999","article-title":"Renal artery stenosis in the antiphospholipid (Hughes) syndrome and hypertension","volume":"62","year":"2003","journal-title":"Annals of the Rheumatic Diseases"},{"key":"ref51","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1034\/j.1600-0609.2003.00145.x","article-title":"Antiphospholipid syndrome and endocrine damage: why bilateral adrenal thrombosis?","volume":"71","year":"2003","journal-title":"European Journal of Haematology"},{"key":"ref81","doi-asserted-by":"crossref","first-page":"999","DOI":"10.1136\/ard.62.10.999","article-title":"Renal artery stenosis in the antiphospholipid (Hughes) syndrome and hypertension","volume":"62","year":"2003","journal-title":"Annals of the Rheumatic Diseases"},{"key":"ref91","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1007\/s10238-016-0430-5","article-title":"The antiphospholipid syndrome: from pathophysiology to treatment","volume":"17","year":"2017","journal-title":"Clinical and Experimental Medicine"},{"key":"ref131","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1097\/00005792-200303000-00005","article-title":"Adrenal involvement in the antiphospholipid syndrome: clinical and immunologic characteristics of 86 patients","volume":"82","year":"2003","journal-title":"Medicine"},{"key":"ref31","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1530\/eje.1.02002","article-title":"Acute adrenal failure as the heralding symptom of primary antiphospholipid syndrome: report of a case and review of the literature","volume":"153","year":"2005","journal-title":"European Journal of Endocrinology"},{"key":"ref41","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1097\/00005792-200303000-00005","article-title":"Adrenal involvement in the antiphospholipid syndrome: clinical and immunologic characteristics of 86 patients","volume":"82","year":"2003","journal-title":"Medicine"},{"key":"ref71","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1210\/edrv.23.3.0466","article-title":"Autoimmune adrenal insufficiency and autoimmune polyendocrine syndromes: autoantibodies, autoantigens, and their applicability in diagnosis and disease prediction","volume":"23","year":"2002","journal-title":"Endocrine Reviews"},{"key":"ref121","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1530\/eje.1.02002","article-title":"Acute adrenal failure as the heralding symptom of primary antiphospholipid syndrome: report of a case and review of the literature","volume":"153","year":"2005","journal-title":"European Journal of Endocrinology"},{"key":"ref141","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1034\/j.1600-0609.2003.00145.x","article-title":"Antiphospholipid syndrome and endocrine damage: why bilateral adrenal thrombosis?","volume":"71","year":"2003","journal-title":"European Journal of Haematology"},{"key":"ref21","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1191\/0961203306lu2318rr","article-title":"Endocrinologic manifestations of the antiphospholipid syndrome","volume":"15","year":"2006","journal-title":"Lupus"},{"key":"ref01","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1007\/s10238-016-0430-5","article-title":"The antiphospholipid syndrome: from pathophysiology to treatment","volume":"17","year":"2017","journal-title":"Clinical and Experimental Medicine"},{"key":"ref111","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1191\/0961203306lu2318rr","article-title":"Endocrinologic manifestations of the antiphospholipid syndrome","volume":"15","year":"2006","journal-title":"Lupus"},{"key":"ref61","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1210\/jc.2015-1710","article-title":"Diagnosis and treatment of primary adrenal insufficiency: An endocrine society clinical practice guideline","volume":"101","year":"2016","journal-title":"Journal of Clinical Endocrinology and Metabolism"}],"container-title":["Endocrinology, Diabetes &amp; Metabolism Case Reports"],"original-title":[],"link":[{"URL":"https:\/\/edm.bioscientifica.com\/view\/journals\/edm\/2018\/1\/EDM18-0118.xml","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/edm.bioscientifica.com\/downloadpdf\/journals\/edm\/2018\/1\/EDM18-0118.xml","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,20]],"date-time":"2026-07-20T13:46:57Z","timestamp":1784555217000},"score":1,"resource":{"primary":{"URL":"http:\/\/journals.bioscientifica.com\/edm\/article\/3356"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,11,22]]},"references-count":18,"URL":"https:\/\/doi.org\/10.1530\/edm-18-0118","relation":{},"ISSN":["2052-0573"],"issn-type":[{"value":"2052-0573","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,11,22]]}}}